MYSE
Myseum Inc.
There isn't enough reported data to score MYSE yet.
MYSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Unavailable |
MYSE's revenue is currently healthy, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
MYSE PE Valuation
MYSE has no meaningful PE right now: it lost money over the past year.
MYSE Forward outlook
There aren't enough analyst estimates for MYSE to show an outlook.
MYSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2021 | -$2.65 | -$1.88 |
| Q2 2021 | -$1.69 | -$0.94 |
| Q1 2021 | -$1.34 | +$1.66 |
| Q4 2020 | -$0.73 | +$4.51 |
MYSE lost $1.25 per share over the past year, a smaller loss than the year before.
MYSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $37 | -53% |
| Q1 2026 | $73 | -12% |
| Q4 2025 | $61 | -34% |
| Q3 2025 | $328 | +429% |
| Q2 2025 | $78 | -48% |
| Q1 2025 | $83 | -37% |
| Q4 2024 | $92 | -46% |
| Q3 2024 | $62 | -65% |
MYSE's revenue is growing: $37 last quarter, down 53% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -5817057% | -4013431 points |
| Q1 2026 | -2308863% | -308326 points |
| Q4 2025 | -1872431% | -663521 points |
| Q3 2025 | -390427% | +1606644 points |
| Q2 2025 | -1803626% | -964485 points |
| Q1 2025 | -2000537% | -730752 points |
| Q4 2024 | -1208910% | -373353 points |
| Q3 2024 | -1997071% | -544413 points |
MYSE's operating margin was −5817057% last quarter, down 4013431 points from the same quarter a year ago, near the bottom of its range since 2022.
MYSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$1.3M | +$154.3K |
| Q1 2025 | -$1.4M | +$71.9K |
| Q4 2023 | -$1.4M | +$161.4K |
| Q3 2023 | -$2M | +$55.6K |
| Q3 2022 | -$2.1M | -$704.1K |
| Q1 2022 | -$2.3M | -$1.6M |
| Q3 2021 | -$1.3M | -$1M |
| Q1 2021 | -$650.2K | -$379.7K |
MYSE has burned cash in almost every quarter: −$4M over the past year, against −$6M the year before.
MYSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +16% | +699K shares |
| 1 year | +18% | +771K shares |
| 3 years | +142% | +2.9M shares |
| 5 years | +272% | +3.6M shares |
MYSE has 5M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
MYSE Net Leverage
MYSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MYSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.4 | Neutral |
| Stochastic | 0.6 | Oversold |
MYSE's weekly RSI is 34 (neutral) and its Stochastic is 1 (oversold).
MYSE PE vs Technology Sector
MYSE has no meaningful PE right now: it lost money over the past year.
MYSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.49 | 29% below |
| 20 week MA | $2.11 | 50% below |
| 50 week MA | $2.05 | 48% below |
| 100 week MA | $2.31 | 54% below |
| 200 week MA | $2.59 | 59% below |
MYSE is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
MYSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $34.2 | $33.9 | -0.9% |
| 2022 | $33.9 | $3.15 | -91% |
| 2023 | $3.15 | $2.87 | -8.9% |
| 2024 | $2.87 | $1.84 | -36% |
| 2025 | $1.84 | $1.87 | +1.6% |
| 2026 YTD | $1.87 | $1.06 | -43% |
MYSE has finished lower in four of the last five years. It's down 43% so far in 2026.